However, serum AFP levels decreased following anti-viral therapy in patients with chronic hepatitis B, and in those patients who demonstrated elevated AFP levels after anti-viral therapy, the risk of HCC was high [25]. This evidence concerns the gene AFP and chronic hepatitis B virus infection.